
Integrating Molecular Profiling and HER2-Targeted Therapies for NSCLC: Best Practices for Testing and Developing Treatment Plans in the Community Setting
Wednesday, April 1, 2026
12:00 p.m. – 1:00 p.m. ET
Please note this TeleECHO program is 12:00 p.m. Eastern, 11:00 a.m. Central, 10:00 a.m. Mountain and 9:00 a.m. Pacific.